FLT3 and acute myeloid leukemia: This case demonstrates that an isolated CNS relapse can occur in acute myeloid leukemia patients who are otherwise in complete hematological and molecular remission, and that targeted therapy, where applicable, as in our case against FLT3, can result in renewed remission.